Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, is focused on developing and commercializing cancer immunotherapy products to harness the power of a patient’s immune system to eradicate cancer cells. It has six ongoing Phase 2 clinical studies, including C-144-01, of its lead product, lifileleucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileleucel for recurrent, metastatic or persistent cervical cancer; and C-145-03, from its candidate product LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; MD Anderson Cancer Center; Ohio State University; Hospitalier Center of the University of Montreal; Cellectis SA; and Novartis Pharma AG.
You want to buy Iovance Biotherapeutics (IOVA) shares, Tutorial Guide
Do you want to buy Iovance Biotherapeutics (IOVA) shares on Nasdaq safely and through a regulated and recognized broker? Does it surprise you to be able to invest your savings every month and make a profit on the stock market? In this tutorial I am going to show you how you can create an account in Degiro , a reliable investment broker with low commissions, and how you can get your first shares in Iovance Biotherapeutics, Inc. (IOVA) (IOVA) quickly and easily. easy.
The method is very intuitive :
- First, we will create an account in Degiro, an investment platform in which we will buy shares of the company Iovance Biotherapeutics, Inc. (IOVA), (IOVA).
- In this step we will make a capital transfer and thus execute the first investment.
- When we already have the funds we have to locate the company Iovance Biotherapeutics by its ticker, IOVA.
- Then we will only have to indicate the number of shares to buy, the price and the type of order.
It is possible that this summary has been too brief for you, so now you are going to see the entire purchase process with screenshots:
How to open your Degiro account
First of all we must register in Degiro from the following link :
It will ask us for an email, a username and a PIN code to access, and then we must continue using the link that they have sent us by email.
Then Degiro will require some essential data in order to corroborate our official identification . We will need to have our passport, ID or driving license, our telephone number and the bank account number that we will use to make our 1st deposit. If you have no idea what this format is, you can review this simple guide article that we have made at Educacep.es .
Once our account is admitted we will have to enter money from the Enter / Withdraw tab. We have the possibility of carrying out a bank transfer that will take two to three days, or proceed to make the deposit quickly using Sofort, a 100% secure and 100% reliable payment gateway.
How to buy Iovance Biotherapeutics (IOVA) shares through Degiro
When we have the money we have the possibility to buy our first share. You can select the Place Order button located in the right corner or explore in the Degiro browser and paste the ticker. In the following screenshot you will see that I have put the Amazon Ticker but you should put (IOVA), the Iovance Biotherapeutics ticker. As it is an action, we will see that the related tickers are listed and there we will see to find Iovance Biotherapeutics. The most important thing is that the ticker, the name of the action and the market in which it is listed coincide. Amazon is listed on Nasdaq (NDQ) and in your case Iovance Biotherapeutics, Inc. (IOVA) is listed on Nasdaq. This step is important so don’t get confused.
At the time of placing the order, we must pay special attention to what I will explain to you . We can place a limit or market order. Imagine that you want to get a share of Iovance Biotherapeutics at 18.32, but its price today is higher. With a limit order, we will enter the value at which we plan to make the purchase and until there are no shares for sale at this price, the purchase operation of the share will not be executed. With a market order DeGiro will buy the number of shares that we have indicated at the true selling price, which will be very similar to the price quoted today.
In any circumstance it is essential that you look at the type of order: fixed or of the day . As an example, in Spain, the stock market price is from morning until 1 in the afternoon, and in the US it corresponds to the afternoon schedule in Spain. If an order is permanent, it will continue until the moment it gets executed, but if you choose the “of the day” option, at the end of the day, if it had not been carried out, it will be removed from your panel from Activity – Orders in process.
I hope that this detailed post has helped you to buy shares in Iovance Biotherapeutics.
| Company information |
|
company executives
| Name | Title | Payment | exercised | Year of birth |
|---|---|---|---|---|
| Dr. Maria Fardis MBA, Ph.D., MBA | CEO, President and Director | 1.2 million | N/A | 1968 |
| Dr. Frederick G. Vogt Ph.D., Esq. | General Counsel and Sec. Corp. | 571.2 thousand | N/A | 1974 |
| Dr. Friedrich Graf Finckenstein MD | Medical director | 458.51k | N/A | 1967 |
| Mr. Jean-Marc Bellemin MBA | Financial Director and Accounting Director | N/A | N/A | 1972 |
| Dr. Igor P. Bilinsky | Director of operations | N/A | N/A | 1973 |
| Ms Sara Pellegrino | Vice President of Investor Relations and Public Relations | N/A | N/A | N/A |
| Mr. Howard B. Johnson | Senior Vice President of Corp. Devel., Alliance Management and Program Management | N/A | N/A | 1960 |
| Dr. Elma S. Hawkins | Board Advisor | N/A | N/A | 1957 |
Recent Iovance Biotherapeutics Events:
Recent Events June 12, 2020 Filed Complete 8-K: Change of Directors or Principal Officers June 02, 2020 Filed Complete 8-K: Other Events, Financial Statements and Exhibits May 29, 2020 Filed Complete 8-K: Other Events, Financial Statements and Exhibits May 27, 2020 Filed Complete 8-K: Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, OtMay 22, 2020 Full Filed 8-K: Other Events, Financial Statements, and Exhibits